Oncology Nurses Are Uniquely Qualified to Meet the Needs of Patients With Lung Cancer
As with all patients with cancer, providing care for those with lung cancer involves both physiological and psychological aspects.
How I Counsel Patients About Lung Cancer Screening
A lung cancer screening navigator offers their perspective on shared decision-making.
Chasing the Target: MET Gene Abnormalities Open New Doors in NSCLC
Capmatinib and tepotinib are highly selective kinase inhibitors targeting MET.
The Uncommon Cancer: Thyroid Carcinoma
Thyroid carcinoma is recognized as one of the most uncommon forms of cancer.
A Difficult Pill to Swallow
Chemotherapy shortages are affecting patients across the country.
Simple Interventions Can Help Oncology Staff Better Communicate With Limited-English Proficiency Patient Populations
Linda Bloom, MPA, RN, OCN, explains how amplifiers and audio interpreter tablets can be vital resources during cancer care.
FDA Grants Elranatamab Accelerated Approval for Relapsed or Refractory Multiple Myeloma
The FDA has granted accelerated approval to elranatamab-bcmm to treat adults with relapsed or refractory multiple myeloma who have already undergone 4 prior lines of treatment.
FDA Approves Niraparib Plus Abiraterone Acetate To Treat BRCA+ mCRPC
The FDA has approved niraparib and abiraterone acetate to treat patients with deleterious or suspected deleterious BRCA-positive mCRPC, as detected by an FDA-approved test.
Olanzapine Significantly Reduces CINV in Patients Receiving MEC
Reimagining Frailty Screenings in Head and Neck Cancer
Screening for Pain and Depression is Not Enough in Cancer Care
Niraparib-Based Triplet Therapy Offers OS Advantage in BRCA1/2+ mCRPC
2 Clarke Drive Cranbury, NJ 08512